Stay updated on Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a minor version update rather than a substantive change to the study details.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page footer has been updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a site/template version refresh without altering the clinical trial record content.SummaryDifference0.0%

- Check45 days agoChange DetectedAdded: Revision v3.5.2; Deleted: Revision v3.5.0.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check82 days agoChange Detected- The page shows a revision label updated from v3.4.2 to v3.4.3, a minor site metadata update that does not alter study content or functionality.SummaryDifference0.0%

- Check110 days agoChange DetectedRevision: v3.4.2 has been added. The notices about government funding and the prior Revision: v3.4.1 have been removed.SummaryDifference0.3%

Stay in the know with updates to Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.